Please login to the form below

Not currently logged in
Email:
Password:

Taltz

This page shows the latest Taltz news and features for those working in and with pharma, biotech and healthcare.

Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales

Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales

This increase can be attributed to Lily’s key growth products, including Trulicity, Verzenio, Olumiant, Tyvyt, Emgality, Jardiance, Retevmo, Cyramza and Taltz.

Latest news

More from news
Approximately 9 fully matching, plus 29 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Understanding behaviour change: A Porterhouse Insights specialism
...
Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...